These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12640270)

  • 21. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes.
    Carnielli VP; Zimmermann LJ; Hamvas A; Cogo PE
    J Perinatol; 2009 May; 29 Suppl 2():S29-37. PubMed ID: 19399007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanded use of surfactant therapy in newborns.
    Lacaze-Masmonteil T
    Clin Perinatol; 2007 Mar; 34(1):179-89, ix. PubMed ID: 17394937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New targets for surfactant replacement therapy: experimental and clinical aspects.
    Robertson B
    Arch Dis Child Fetal Neonatal Ed; 1996 Jul; 75(1):F1-3. PubMed ID: 8795348
    [No Abstract]   [Full Text] [Related]  

  • 25. Surfactant reduced the mortality of neonates with birth weight ⩾1500 g and hypoxemic respiratory failure: a survey from an emerging NICU network.
    Wang H; Gao X; Liu C; Yan C; Lin X; Dong Y; Sun B
    J Perinatol; 2017 Jun; 37(6):645-651. PubMed ID: 28151493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of surfactant beyond respiratory distress syndrome, what is the evidence?
    Desai RK; Yildiz Atar H; Lakshminrusimha S; Ryan RM
    J Perinatol; 2024 Apr; 44(4):478-487. PubMed ID: 38459371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Secondary surfactant deficiencies].
    Escande B; Kuhn P; Rivera S; Messer J
    Arch Pediatr; 2004 Nov; 11(11):1351-9. PubMed ID: 15519836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent clinical trials of surfactant treatment for neonates.
    Halliday HL
    Biol Neonate; 2006; 89(4):323-9. PubMed ID: 16770072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous positive airway pressure and surfactant.
    Bohlin K; Jonsson B; Gustafsson AS; Blennow M
    Neonatology; 2008; 93(4):309-15. PubMed ID: 18525215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants.
    Wang H; Gao X; Liu C; Yan C; Lin X; Yang C; Lin Z; Zhu W; Yang Z; Yu F; Qiu Y; Liu X; Zhou X; Chen C; Sun B;
    Pediatrics; 2012 Mar; 129(3):e731-40. PubMed ID: 22331337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surfactant therapy in full-term neonates with severe respiratory failure.
    Khammash H; Perlman M; Wojtulewicz J; Dunn M
    Pediatrics; 1993 Jul; 92(1):135-9. PubMed ID: 8516059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant replacement in preterm infants with respiratory distress syndrome.
    Dani C
    Acta Biomed; 2012; 83 Suppl 1():17-20. PubMed ID: 23029871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanded use of surfactant replacement therapy.
    Greenough A
    Eur J Pediatr; 2000 Sep; 159(9):635-40. PubMed ID: 11014460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exogenous surfactant: intubated present, nebulized future?
    Shah S
    World J Pediatr; 2011 Feb; 7(1):11-5. PubMed ID: 20549420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal Respiratory Diseases in the Newborn Infant: Novel Insights from Stable Isotope Tracer Studies.
    Carnielli VP; Giorgetti C; Simonato M; Vedovelli L; Cogo P
    Neonatology; 2016; 109(4):325-33. PubMed ID: 27251153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within the minimally invasive surfactant therapy approach in preterm infants: a randomised controlled trial.
    Oncel MY; Arayici S; Uras N; Alyamac-Dizdar E; Sari FN; Karahan S; Canpolat FE; Oguz SS; Dilmen U
    Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F323-8. PubMed ID: 26553376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surfactant for meconium aspiration syndrome in full term/near term infants.
    El Shahed AI; Dargaville P; Ohlsson A; Soll RF
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002054. PubMed ID: 17636695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    Yost CC; Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.